EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinomaYuan Li(Sun Yat-sen University), Lin‐Quan Tang(Sun Yat-sen University)Cell Death and DifferentiationFebruary 1, 202210.1038/s41418-022-00939-8Cited by 148SaveCiteExport RISWatch citationsRelated PapersCamrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial|Nature Communications|2023|45